June 8, 2021
Sanofi launches its new global employee share ownership plan
Sanofi launches its new global employee share ownership plan PARIS – June 7, 2021 – Sanofi today launches Action 2021, its…
Pharmaceuticals, Biotechnology and Life Sciences
Sanofi launches its new global employee share ownership plan PARIS – June 7, 2021 – Sanofi today launches Action 2021, its…
Monthly information related to total number of voting rights and shares composing the…
VALNEVA Déclaration d’actions et de droits de vote – Mai 2021 Dénomination sociale : VALNEVAAdresse du siège social : 6 rue Alain…
HANGZHOU, China, June 06, 2021 (GLOBE NEWSWIRE) — AnHeart Therapeutics Co., Ltd (“AnHeart”), a clinical stage oncology company focused on…
Median Duration of Response (DOR) Not Reached at 33.1 Months of Median Study Follow Up in Cohort 2 in C-144-01 Study…
Phase II primary endpoint results for investigational iptacopan in IgAN demonstrated effective and clinically meaningful reduction of proteinuria1 – a…
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWS…
– In pivotal Phase 3 JUPITER-02 study, toripalimab plus chemotherapy significantly improved PFS compared to chemotherapy alone in high and…
At final analysis, study showed clinically relevant improvement in median overall survival with a difference of 11.7 months between arms…
– In pivotal Phase 3 JUPITER-02 study, toripalimab plus chemotherapy significantly improved PFS compared to chemotherapy alone in high and…